Crossmark

HER3 beyond the canonical paradigm: a versatile signaling hub in oncogenesis and therapeutic resistance

Published Online: 2026-03-12

Authors

Li, Ying

Wang, Zhuo

Gu, Meichen

Huang, Fuxue

Chang, Pengyu https://orcid.org/0000-0001-9047-7942
License Information

Text and Data Mining valid from 2026-03-12

Accepted Manuscript valid from 2026-03-12
More Information

Article History

Received: 14 December 2025

Accepted: 21 February 2026

First Online: 12 March 2026

Declarations

:

: Not applicable.

: Not applicable.

: The authors report no competing interests.

Document is current